Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) System has now been added to the Alberta Drug Benefit List. In addition, the Alberta government has expanded the ...

Redburn Atlantic upgraded DexCom (DXCM) to Buy from Neutral with a price target of $115, up from $85. The company is positioned to benefit from ...

(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ...

Bundling in Dexcom’s CGM tech will “improve health outcomes by delivering actionable insights in one connected system,” he added. Lilly isn’t the first diabetes specialist to tap into ...

Riverstone Advisors LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 14.0% in the fourth quarter, ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from Leerink Partners maintained a Buy rating on the ...

Notably, Dexcom, Abbott Laboratories ... distinguished for integrating advanced technology into its CGM products. The Medtronic Guardian Connect system not only monitors glucose levels but ...